Evidence map›Paper›PMID 31484472›Full record

ArticleBiomolecules & therapeutics2019

Functional Characterization of Pharmcogenetic Variants of Human Cytochrome P450 2C9 in Korean Populations.

Myung-A Cho, Jihoon G Yoon, Vitchan Kim, Harim Kim, Rowoon Lee, Min Goo Lee, Donghak Kim

Open access · greenAbstract read
In one paragraph

Article in Biomolecules & therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Functional Assessment of 12 Rare AllelicJournal of personalized medicine · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Myung-A ChoDepartment of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea.
Jihoon G YoonDepartment of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Vitchan KimDepartment of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea.
Harim KimDepartment of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea.
Rowoon LeeDepartment of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea.
Min Goo LeeDepartment of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Donghak KimDepartment of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea.
Konkuk University · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human cytochrome P450 2C9 is a highly polymorphic enzyme that is required for drug and xenobiotic metabolism. Here, we studied eleven P450 2C9 genetic variants-including three novel variants F69S, L310V, and Q324X-that were clinically identified in Korean patients. P450 2C9 variant enzymes were expressed in

Indexed as

Cytochrome P450DiclofenacP450 2C9PharmacogeneticsPolymorphism

Identifiers

PMID31484472
PMCPMC6824622
OpenAlexW2971545401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.